The THERACAN project, led by UiT The Arctic University of Norway and the University Hospital of North Norway (UNN), aims to develop this approach for more advanced cancers, including brain cancer. The goal is to provide more personalised treatment, fewer side effects and better outcomes for patients who have limited treatment options today.

Read the whole opinion piece in Dagens Medisin (the text is in norwegian).